In the SURPASS-2 trial, which directly compared tirzepatide to semaglutide 1 mg for type 2 diabetes, nausea rates were 17-22% for tirzepatide across all three dose levels (5 mg, 10 mg, and 15 mg) versus 18% for semaglutide 1 mg
Scott Froum, DDS, a graduate of the State University of New York, Stony Brook School of Dental Medicine, is a periodontist in private practice at 1110 2nd Avenue, Suite 305, New York City, New York
The Mature Skin Reality Check: For many of us with reactive skin in our 40s and 50s, retinol comes with redness, peeling, and extreme dryness - and that's because our skin naturally loses the lipids that maintain its protective barrier
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes